Search clinical trials for: Quetiapine & Placebo

Total 54138 results

University of Cincinnati

Completed

Quetiapine in Melancholic Depression

Depression | Healthy

United States
Subhajit Chakravorty

Completed

The Effects of Quetiapine (Seroquel XR) on Sleep During Alcohol Abstinence

Alcoholism | Sleep Initiation and Maintenance Disorders

United States
Astellas Pharma Inc

Completed

Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder

Major Depressive Disorder

Japan
Otsuka Pharmaceutical Development & Commercialization...
PRA Health Sciences

Completed

Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

Schizophrenia | Bipolar Disorder

United States
Fundación Instituto de Estudios de Ciencias de...
Instituto de Investigación Biomédica de Salamanca; Grupo Español de Rehabilitación...

Terminated

Clinical Trial With Quetiapine Prophylaxis Postoperative Delirium in High Risk Surgical Patients

Postoperative Delirium

Spain
University of Texas Southwestern Medical Center

Completed

Quetiapine for Bipolar Disorder and Alcohol Dependence

Alcohol Dependence | Bipolar Disorder

United States
Severance Hospital

Unknown

Effects of 'Seroquel-XR' on the Improvement of Neurocognitive Function in People At-risk Mental States(ARMS) (ES-ARMS)

Schizophrenia | Abnormal Mental State

Korea, Republic of
McMaster University

Completed

Quetiapine Extended Release (XR) for the Treatment of Menopausal Depression

Insomnia | Hot Flashes | Major Depressive Disorder

Canada
Seattle Institute for Biomedical and Clinical Research
AstraZeneca; VA Puget Sound Health Care System

Completed

Quetiapine for the Reduction of Cocaine Use (AZC)

Substance Abuse | Cocaine Dependence | Drug Abuse | Cocaine Abuse | Cocaine Addiction

United States
AstraZeneca

Completed

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Bipolar Depression
Holly Swartz
National Institute of Mental Health (NIMH)

Completed

Acute Psychotherapy for Bipolar II Depression

Depression | Bipolar Disorder

United States
University Hospital Muenster
AstraZeneca

Completed

Quetiapine in Specific Phobia (QUISS)

Specific Phobia

Germany
University of Cincinnati
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

SGA-induced Metabolic Syndrome in Bipolar Youth

Bipolar Youth Treated With Second-generation Antipsychotics

United States
Janssen-Cilag International NV

Completed

A Long-term Comparison of Esketamine Nasal Spray Versus Quetiapine Extended Release, Both in Combination With a Selective Serotonin Reuptake Inhibitor/Serotonin-Norepinephrine Reuptake Inhibitor, in Participants With Treatment Resistant Major Depressive Disorder (ESCAPE-TRD)

Depressive Disorder, Major

Israel, Hungary, Korea, Republic of, Taiwan, Portugal, Turkey, Germany, Malaysia, Denmark, Bulgaria, Czechia, Belgium, Poland, Brazil, Netherlands, Argentina, Finland, Greece, South Africa, Austria, Kazakhstan, Norway, Sweden, United...
Inje University

Unknown

The Effect of Quetiapine XR in Depressive Patients Showing Aberrant N100 Amplitude Slope

Major Depressive Disorder

Korea, Republic of
University of Cincinnati
AstraZeneca

Completed

A Double-Blind Randomized Placebo Controlled Study of Quetiapine for the Treatment of Depression in Adolescents With Bipolar Disorder

Bipolar I Disorder

United States
New Mexico VA Healthcare System
AstraZeneca

Completed

Schizophrenia Sensory Gating Deficit With Quetiapine

Schizophrenia

United States
Arthur P. Noyes Research Foundation

Unknown

Quetiapine Decreases Smoking in Patients With Chronic Schizophrenia

Smoking Behavior in Schizophrenia

United States
Lone Baandrup
Region Capital Denmark; Mental Health Services in the Capital Region, Denmark; Danish Center for Sleep Medicine and other collaborators

Recruiting

Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia (MEL-QUE)

Insomnia | Psychiatric Disorders

Denmark
King's College London
University of Oxford; Newcastle University; South London and Maudsley NHS Foundation... and other collaborators

Recruiting

Lithium Versus Quetiapine in Treatment Resistant Depression (LQD)

Depressive Disorder, Treatment-Resistant

United Kingdom
Astellas Pharma Inc

Completed

Long-term Study of FK949E in Elderly Bipolar Disorder Patients

Bipolar Disorder | Elderly

Japan
Cambridge Health Alliance

Completed

Post-Traumatic Stress Disorder (PTSD) and Seroquel

Post-Traumatic Stress Disorder

United States
University of Tennessee Graduate School of Medicine

Completed

Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients

Psychomotor Agitation

United States
AstraZeneca

Completed

Seroquel on Glucose Metabolism

Schizophrenia

Bulgaria, Czech Republic, South Africa, United Kingdom, Germany, Hungary, Romania, Slovakia, Norway
AstraZeneca

Completed

Relapse Prevention, RoW: Study to Evaluate Prevention of Relapse in Patients in Stable Chronic Schizophrenia Receiving Either Seroquel or Placebo

Schizophrenia

Bulgaria, Poland
University of British Columbia
AstraZeneca

Completed

The Effects of Quetiapine XR on Cognition, Mood and Anxiety Symptoms in SSRI-Resistant Unipolar Depression

Unipolar Depression

Canada
AstraZeneca

Completed

Fast Titration in the Treatment of Schizophrenia, Taiwan

Schizophrenia

Taiwan
Université de Montréal
AstraZeneca

Completed

The Impact of Quetiapine on the Drug Abuse Patterns of Addicted Schizophrenic Patients

Schizophrenia | Substance Use Disorders

Canada
Birte Glenthoj
AstraZeneca; Rigshospitalet, Denmark; University of Copenhagen; Glostrup University... and other collaborators

Completed

Neurobiological and Neurocognitive Disturbances in First-episode Schizophrenia

Schizophrenia

Denmark
AstraZeneca

Terminated

Efficacy of Quetiapine in Generalised Social Anxiety Disorder

Social Anxiety Disorder

Netherlands
AstraZeneca

Completed

Fast Titration Of Quetiapine Versus Currently Approved Titration

Psychotic Disorders

Norway
AstraZeneca

Completed

Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder

Major Depressive Disorder

Russian Federation, United States, Estonia, Ukraine, Finland, Argentina
University of Vermont
AstraZeneca; National Center for Research Resources (NCRR)

Unknown

Quetiapine for the Treatment of Insomnia in Alzheimer's Disease

Insomnia | Alzheimer's Disease

United States
AstraZeneca

Completed

Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects

Schizophrenia | Schizoaffective Disorders

Canada
Lindner Center of HOPE
AstraZeneca; University of Cincinnati

Completed

Study of Quetiapine Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomanic Symptoms or Mild Manic Symptoms

Bipolar Disorder

United States
Mood Disorders Center of Ottawa
AstraZeneca

Completed

Quetiapine (Seroquel) Maintenance Treatment in Early Onset Bipolar Spectrum Disorders

Bipolar Disorder

Canada
Duke University
AstraZeneca

Completed

Quetiapine in Social Anxiety Disorder

Social Anxiety Disorder

United States
Assiut University

Not yet recruiting

Sleep Disorders in Chronic Kidney Disease Patients

Chronic Kidney Diseases
Verinder Sharma

Recruiting

The Safety, Tolerability, and Effectiveness of Quetiapine in Postpartum Depression

Postpartum Depression

Canada
Laboratorio Elea Phoenix S.A.
DominguezLab S.R.L.

Completed

Bioequivalence Study of Two Extended Release Formulations Containing 50 mg of Quetiapine.

Healthy

Argentina
University of South Florida
University of California, San Diego

Terminated

A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study

Anorexia Nervosa

United States
The University of Hong Kong

Completed

Antipsychotic Therapy and First Episode

Schizophrenia

Hong Kong
National Institute on Aging (NIA)

Completed

Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)

Parkinson Disease | Dementia

United States
Loyola University

Completed

Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients

Depression | Anxiety

United States
Ruhr University of Bochum

Completed

Quetiapine in the Treatment of Psychotic Depression - a Pilot Study

Psychotic Depression

Germany
AstraZeneca

Completed

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania (ANCHOR 149)

Bipolar Disorder

United States
AstraZeneca

Completed

Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Major Depressive Disorder (MOONSTONE)

Major Depressive Disorder

United States
National Center for Research Resources (NCRR)
Northwestern University

Completed

Phase II Study of Lactulose and Circadian Rhythms in Patients With Cirrhosis

Hepatic Encephalopathy | Cirrhosis | Portal Hypertension
Astellas Pharma Inc

Completed

Study to Evaluate the Effects of Switching Different Strength Forms of FK949E in Bipolar Disorder Patients With Major Depressive Episodes

Bipolar Depression

Japan
Cambridge Health Alliance
AstraZeneca

Completed

Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults

Social Anxiety Disorder

United States

Search clinical trials for: Quetiapine & Placebo

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations